Adam D. Levy

ACRV

Adam D. Levy serves as officer: Chief Financial Officer at Acrivon Therapeutics, Inc. Common Stock (ACRV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$30.0K

Total Sells

1 trades

$1.5K

Net Position

Net Buyer

$28.5K

Companies Traded

ACRV

Active Period

Aug 2025 – Jan 2026

3 total trades

Most Recent

Buy ACRV

Jan 16, 2026 · $15.0K

Adam D. Levy's Insider Trading at Acrivon Therapeutics, Inc. Common Stock (ACRV)

Buys

2 · $30.0K

Sells

1 · $1.5K

Total Shares Bought

17,664

Total Shares Sold

1,164

ACRV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 16, 2026↗	Buy	8,832	$1.70	$15.0K	20,983
Jan 14, 2026↗	Buy	8,832	$1.70	$15.0K	0
Aug 1, 2025↗	Sell	1,164	$1.26	$1.5K	0

Related Insiders

Katharine Peterson

Chief Accounting Officer

ACRVSell · Feb 14, 2026

Peter Blume-Jensen

President and CEO

ACRVSell · Feb 14, 2026

Eric Devroe

Chief Operating Officer

ACRVSell · Feb 14, 2026

Erick Gamelin

Chief Development Officer

ACRVSell · Feb 14, 2026

Mary Miller

Chief Legal Officer

ACRVSell · Feb 14, 2026

Peter Blume-Jensen

director, officer: President and CEO

ACRVBuy · Jan 14, 2026

Eric Devroe

officer: Chief Operating Officer

ACRVBuy · Jan 13, 2026

Explore More Insider Trading Data

ACRV Insider Trading Activity

View all insider trades at Acrivon Therapeutics, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity